Small Molecule Outsourcing STREAM

  1. Formulating Better ASDs And mAbs: Advances In Applied Nanotechnology 5/1/2024

    Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.

  2. Solvent-Free, Fusion-Based Amorphic Dispersion Process 7/11/2024

    Discover a solvent-free, fusion-based process that leverages frictional and shear forces to rapidly convert crystalline drugs and polymers into amorphous solid dispersions (ASDs).

  3. Cambrex Scientist Spotlight: Luigi Bellone 1/29/2025

    Luigi Bellone, Head of Quality Assurance in Paullo, Milan, brings over 20 years of experience in quality assurance (QA), quality control (QC), and regulatory compliance within the pharmaceutical industry.

  4. From Bench To Batch: Strategies For Scaling HPAPI Production

    Highly potent materials bring additional challenges to manufacturing processes. Examine considerations for optimizing HPAPI production methods to reduce risk and deliver therapies to patients with speed.

  5. Environmental Sustainability: Wastewater Incineration Reduction

    Discover an approach to wastewater treatment that reduces the environmental impact of small molecules production and introduces advanced treatment methodologies to avoid wastewater incineration.

  6. Collaboration With Clients 1/29/2025

    If you're looking for a dedicated partner who prioritizes trust, transparent communication, and delivering results that exceed expectations, let's work together to drive your project's success and create lasting impact.

  7. Taste Masking 101: Sensory And Performance Evaluation 7/11/2022

    Learn how techniques and innovations in taste masking sensory and performance evaluation can help accelerate your formulation development and confirm desired taste profile.

  8. Rapid, Material-Sparing Feasibility Screening For Hot Melt Extrusion

    Discover a screening process to quickly assess HME feasibility that yields more accurate predictions for API loading and degradation while saving material and time compared to traditional approaches.

  9. How Drug Delivery Is Enabling A Clinical Trial For Glioblastoma

    Discover highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM).

  10. How To Deal With The Complexity Of Drugs In Clinical Development

    Discover how to advance new compounds with complex chemistry through each stage of development by refining processes to give fit-for-purpose manufacturability and yields.